O
ORIC
ORIC製藥
7.50
-0.52-6.48%After Hours: 7.84 +0.34 +4.53%19:46 06/05 EDT
OPEN/PREV CLOSE8.00/8.02
TODAY RANGE7.48-8.12
VOL1.25M
MARKET CAP776.38M
52 WEEK RANGE7.23-14.93
AVG VOL (3M)1.92M
% TURNOVER1.20%
TURNOVER--
P/E (TTM)-5.2426
% RANGE7.98%
EPS(TTM)-1.4306
P/E(FORWARD)-5.2601
P/B1.868
BVPS4.016
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP710.76M
SHARES OUTSTANDING103.52M
NEXT EARNINGS08/10-08/14
FREE FLOAT94.77M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·4d ago
Tuesday's ETF Movers: XSD, XBI
TipRanks·05/15 09:11
Oric Pharmaceuticals moved to Buy rating at Goldman Sachs
Dow Jones·05/05 16:04
Oric Pharmaceuticals Is Maintained at Buy by Citigroup
Dow Jones·05/05 16:04
Oric Pharmaceuticals Price Target Cut to $16.00/Share From $17.00 by Citigroup
Benzinga·05/05 15:54
Citigroup Maintains Buy on ORIC Pharmaceuticals, Lowers Price Target to $16
TipRanks·05/05 13:46
Oric Pharmaceuticals (ORIC) Initiated with a Buy at Wedbush
TipRanks·05/05 11:18
Guggenheim Remains a Buy on Oric Pharmaceuticals (ORIC)
TipRanks·05/05 11:18
Oric Pharmaceuticals (ORIC) Receives a Buy from Wells Fargo
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.